Abstract:Objectives To evaluate the role of systemic arterial embolization in patients with primary and metastatic lung tumors presenting with hemoptysis requiring emergent management. Patients and Methods This retrospective single-center study evaluated patients undergoing transarterial embolization for emergent hemoptysis. Endpoints included technical success, clinical success and overall survival. Clinical success was divided into partial or complete, and defined as absence (complete) or sub-total (partial) reduction in frequency and/or volume of hemoptysis in the first 24-hours following embolization. Predictive factors for clinical outcomes were evaluated using univariate analysis. Adverse events were graded according to Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Results Thirty-seven patients were identified, including 21/37 (56.8%) patients with primary lung cancer. Clinical success was achieved in 31/37 (83.8%) patients. Median overall survival was 18 days (95% CI: 10 to 95). Median hemoptysis-free survival was 270 days (95% CI: 7 to not reached). No significant predictors of hemoptysis-free survival were identified. Prior chemotherapy (HR 2.69, 95% CI: 1.08-6.67, p -value = 0.03) was associated with poorer overall survival. History of primary lung tumor (vs metastatic tumor) was associated with improved overall survival (HR 0.45, 95% CI: 0.21-0.95, p-value = 0.04). No serious adverse events (CTCAE Grade ≥ 3) were found to be directly attributable to the embolization. Conclusion Hemoptysis requiring emergent management in patients with lung malignancy carries a poor prognosis. Transarterial embolization is feasible, safe and may be an effective management option, although further research is warranted to identify which patients are likely to derive the greatest benefit. Micro abstract Embolization of hemoptysis requiring emergent treatment is feasible and safe. History of prior chemotherapy is associated with poorer overall survival. Patients with primary lung tumors have relatively improved overall survival. Prognosis remains poor despite intensive therapeutic and supportive management

Bronchial Artery Chemoembolization for Hemoptysis in Advanced Primary Lung Cancer

Cortical Blindness and Ataxia Complicating Bronchial Artery Embolization for Severe Hemoptysis

Bronchial Artery Embolization for Hemoptysis: A Systematic Review and Meta-Analysis

Application of Bronchial Arterial Chemoembolization for Treating Advanced Lung Cancer

Bronchial artery chemoembolization in the treatment of refractory central lung cancer with atelectasis

The efficacy and safety of combined therapy with endobronchial tamponade and bronchial artery embolization for massive hemoptysis

Bronchial Artery Embolization in Pediatric Pulmonary Hemorrhage: A Single-Center Experience

Treatment of massive hemoptysis by superselective bronchial artery embolization

Bronchial artery embolization versus conservative treatment for hemoptysis: a systematic review and meta-analysis

Combination of Bronchial Arterial Infusion Chemotherapy plus Drug-Eluting Embolic Transarterial Chemoembolization for Treatment of Advanced Lung Cancer—A Retrospective Analysis of 23 Patients

Transarterial embolization for the management of emergent hemoptysis in patients with primary and metastatic lung tumors

Drug-eluting Beads Bronchial Arterial Chemoembolization As a Neoadjuvant Treatment for Squamous Non-Small Cell Lung Cancer.

Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database

Clinical Study of Interventional Preoperative Bronchial Artery Infusion Chemotherapy Combined with Surgical Resection for Lung Cancer

Clinical Study of Interventional Preoperative Bronchial Arterial Infusion Chemotherapy Combining with Surgery Resection to Lung Cancer: P2-287

Comparison of Clinical Efficacy Between Arterial Infusion and Embolization with Arterial Infusion and Argon Plasma Coagulation in the Treatment of Patients with Advanced Central Type Lung Cancer

Effect Of Bronchial Artery Embolisation On The Management Of Tuberculosis-Related Haemoptysis

Case Report: Bronchial Artery Embolization and Chemoradiotherapy for Central Squamous Cell Lung Carcinoma with Rapid Regression

Interventional Treatment of Hemoptysis Associated with Pulmonary Embolism

Comparison of n-butyl-2-cyanoacrylate and polyvinyl alcohol particles for bronchial artery embolisation in primary lung cancer: a retrospective cohort study

Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China